Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherThis Month in JNM

THIS MONTH IN JNM

Journal of Nuclear Medicine January 2006, 47 (1) 7a-8a;
  • Article
  • Info & Metrics
  • PDF
Loading

Lewis reviews past research and current promise of the sodium/iodide symporter in reporter gene imaging and therapy and previews an article on the same topic in this issue.
Page 1

DeNardo comments on the scientific significance of a study in this issue on the use of 2 biologic agents to achieve targeted molecular therapeutic synergy by coactivation or blockade of cancer cell signaling pathways.
Page 4

Van Den Bossche and colleagues assess the ability of sequential 99mTc-depreotide scintigraphy to provide accurate and very early prediction of responses to endocrine therapy in patients with advanced breast cancer.
Page 6

Figure

Kalff and colleagues evaluate prognostic information obtained from postchemoradiation 18F-FDG PET imaging in patients with locally advanced rectal cancer undergoing radical surgery with curative intent.
Page 14

Lodge and colleagues compare the performance of 2- and 3-dimensional acquisition in whole-body 18F-FDG PET imaging using a lutetium oxyorthosilicate–based tomograph in patients undergoing oncology management evaluations.
Page 23

Metser and colleagues report on the utility of 18F-FDG PET/CT, with data from both the PET and the unenhanced CT portions of the study, in distinguishing benign from malignant adrenal lesions in patients with cancer.
Page 32

Buchert and colleagues detail the use of 11C-(+)McN5652 PET to assess age-related declines in available brain serotonin transporter in young, healthy individuals and the implications of these results for age-dependent correction in SPECT and PET studies.
Page 38

Fujimura and colleagues investigate the binding of the PET ligand 18F-FEDAA1106 to peripheral benzodiazepine receptors in healthy men and present a method for quantitative analysis of findings.
Page 43

Nishina and colleagues report on the comparative diagnostic value of prone imaging alone and combined acquisition in myocardial perfusion SPECT assessment for coronary artery disease in a large series of patient studies.
Page 51

Figure

Sdringola and colleagues use dipyridamole PET to compare changes in perfusion defects throughout the coronary vascular tree and in worst flow-limiting stenoses as predictors of coronary events in long-term follow-up and relate these changes to treatment regimens.
Page 59

Schinkel and colleagues research the utility of 18F-FDG SPECT imaging in predicting improvement of left ventricular function and heart failure symptoms after coronary revascularization in patients with diabetes mellitus and ischemic dysfunction.
Page 68

Figure

Berman and colleagues review current applications and interactions of noninvasive imaging approaches—including nuclear cardiology, cardiac CT, and cardiac magnetic resonance—in assessment of patients with suspected coronary artery disease.
Page 74

Matsumoto and colleagues describe a new dedicated PET unit that offers 3-dimensional continuous-emission and spiral-transmission scanning and evaluate its performance using the National Electrical Manufacturers Association NU 2-2001 standard.
Page 83

Beyer and colleagues investigate the effect of CT truncation in whole-body PET/CT imaging of large patients and describe the efficacy of an extended field-of-view correction technique.
Page 91

Figure

Cropley and colleagues estimate radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans, using dynamic whole-body PET imaging in healthy volunteers.
Page 100

Figure

Ferrari and colleagues calculate values for dosimetry of locoregional brain treatments with several 90Y-labeled compounds and report initial safety and efficacy results in 12 patients treated with 90Y-DOTATOC.
Page 105

Zhang and colleagues report on quantitative PET imaging of tumor integrin αvβ3 expression with the dimeric RGD peptide 18F-FRGD2 and evaluate its promise in antiangiogenic therapy assessment and drug development.
Page 113

Capello and colleagues evaluate the biodistributions of novel peptide compounds RGD-111In-DTPA-octreotate and 125I-RGD-octreotate in rats and investigate the caspase-3 activation of the unlabeled compound RGD-DTPA-octreotate in vitro.
Page 122

Xiong and colleagues describe chemical modification of an adenovirus targeting integrin αvβ3–expressing tumors and outline methods for PET monitoring of in vivo transfectivity of vectors in this promising gene delivery approach.
Page 130

Förster and colleagues detail the results of 4 different methods designed to reduce kidney uptake of radiolabeled DOTA-biotin for multistep immune targeting approaches in radioimmunotherapy.
Page 140

Figure

van Waarde and colleagues compare the biodistribution and tumor selectivity of 4 PET tracers (2 σ-receptor ligands and 2 11C-labeled compounds) with those of 18F-FLT and 18F-FDG in a rat model.
Page 150

Aruva and colleagues report on the synthesis of a novel 99mTc-pentapeptide with high affinity for α-chain-fibrin and assess its efficacy in imaging experimental deep vein thrombosis and pulmonary embolism in a swine model.
Page 155

Figure

Rimoldi and colleagues research the feasibility and accuracy of quantifying subendocardial and subepicardial myocardial blood flow and relative coronary flow reserves using 15O-labeled water and 3-dimensional–only PET in a swine model.
Page 163

DeGrado and colleagues report on validation studies of 18F-FTP as a metabolically trapped fatty acid oxidation probe in an isolated perfused rat heart model, examining effects of both hypoxia and changes in exogenous fatty acid availability.
Page 173

Vadysirisack and colleagues investigate whether posttranslational processing and cell-surface trafficking of the sodium/iodide (NIS) symporter affect mediated radioiodide uptake in cells expressing exogenous NIS and discuss the implications for monitoring gene therapy.
Page 182

ON THE COVER

A replication-deficient Ad vector carrying HSV1-39tk packed as a reporter gene on CMV promoter has successfully been modified using bifunctional PEG. The natural tropism of the virus was ablated even at a low rate of modification. The addition of cyclic RGD peptide enhanced transduction in cells expressing integrin αvβ3. This enhancement depended on binding of the peptide to integrin and was independent of viral receptors. Trans duction in nontarget tissues was markedly decreased after intravenous delivery of the modified vector, suggesting that PEGylation may help reduce in vivo sequestration of the vector.

Figure

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 47 (1)
Journal of Nuclear Medicine
Vol. 47, Issue 1
January 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
THIS MONTH IN JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
THIS MONTH IN JNM
Journal of Nuclear Medicine Jan 2006, 47 (1) 7a-8a;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
THIS MONTH IN JNM
Journal of Nuclear Medicine Jan 2006, 47 (1) 7a-8a;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • A “New” Reporter in the Field of Imaging Reporter Genes: Correlating Gene Expression and Function of the Sodium/Iodide Symporter
  • Combined Molecular Targeting for Cancer Therapy: A New Paradigm in Need of Molecular Imaging
  • Early Prediction of Endocrine Therapy Effect in Advanced Breast Cancer Patients Using 99mTc-Depreotide Scintigraphy
  • Findings on 18F-FDG PET Scans After Neoadjuvant Chemoradiation Provides Prognostic Stratification in Patients with Locally Advanced Rectal Carcinoma Subsequently Treated by Radical Surgery
  • Comparison of 2-Dimensional and 3-Dimensional Acquisition for 18F-FDG PET Oncology Studies Performed on an LSO-Based Scanner
  • 18F-FDG PET/CT in the Evaluation of Adrenal Masses
  • Is Correction for Age Necessary in SPECT or PET of the Central Serotonin Transporter in Young, Healthy Adults?
  • Quantitative Analyses of 18F-FEDAA1106 Binding to Peripheral Benzodiazepine Receptors in Living Human Brain
  • Combined Supine and Prone Quantitative Myocardial Perfusion SPECT: Method Development and Clinical Validation in Patients with No Known Coronary Artery Disease
  • Mechanisms of Progression and Regression of Coronary Artery Disease by PET Related to Treatment Intensity and Clinical Events at Long-Term Follow-up
  • Impact of Diabetes Mellitus on Prediction of Clinical Outcome After Coronary Revascularization by 18F-FDG SPECT in Patients with Ischemic Left Ventricular Dysfunction
  • Roles of Nuclear Cardiology, Cardiac Computed Tomography, and Cardiac Magnetic Resonance: Assessment of Patients with Suspected Coronary Artery Disease
  • Performance Characteristics of a New 3-Dimensional Continuous-Emission and Spiral-Transmission High-Sensitivity and High-Resolution PET Camera Evaluated with the NEMA NU 2-2001 Standard
  • Whole-Body 18F-FDG PET/CT in the Presence of Truncation Artifacts
  • Whole-Body Biodistribution and Estimation of Radiation-Absorbed Doses of the Dopamine D1 Receptor Radioligand 11C-NNC 112 in Humans
  • Dosimetric Model for Locoregional Treatments of Brain Tumors with 90Y-Conjugates: Clinical Application with 90Y-DOTATOC
  • Quantitative PET Imaging of Tumor Integrin αvβ3 Expression with 18F-FRGD2
  • Anticancer Activity of Targeted Proapoptotic Peptides
  • Imaging Chemically Modified Adenovirus for Targeting Tumors Expressing Integrin αvβ3 in Living Mice with Mutant Herpes Simplex Virus Type 1 Thymidine Kinase PET Reporter Gene
  • Pretargeted Radioimmunotherapy with a Single-Chain Antibody/Streptavidin Construct and Radiolabeled DOTA-Biotin: Strategies for Reduction of the Renal Dose
  • Comparison of Sigma-Ligands and Metabolic PET Tracers for Differentiating Tumor from Inflammation
  • Imaging Thromboembolism with Fibrin-Avid 99mTc-Peptide: Evaluation in Swine
  • Quantification of Subendocardial and Subepicardial Blood Flow Using 15O-Labeled Water and PET: Experimental Validation
  • Validation of 18F-Fluoro-4-Thia-Palmitate as a PET Probe for Myocardial Fatty Acid Oxidation: Effects of Hypoxia and Composition of Exogenous Fatty Acids
  • Correlation of Na+/I− Symporter Expression and Activity: Implications of Na+/I− Symporter as an Imaging Reporter Gene
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire